You are here

Article Text

Article menu
Download PDFPDF
Editorial commentary
Collateral status as the fifth dimension: warping the time clock for endovascular treatment in acute ischaemic stroke
  1. Xinyi Leng1,
  2. David S Liebeskind2
  1. 1 Departments of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China
  2. 2 Neurovascular Imaging Research Core and UCLA Stroke Center, Department of Neurology, University of California Los Angeles, Los Angeles, California, USA
  1. Correspondence to Dr David S Liebeskind, Neurovascular Imaging Research Core and UCLA Stroke Center, Department of Neurology, University of California Los Angeles, Los Angeles, CA 90095, USA; davidliebeskind{at}yahoo.com

https://doi.org/10.1136/jnnp-2018-318258

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Endovascular treatment (EVT) has radically transformed the treatment of acute ischaemic stroke during the last few years. A meta-analysis of individual data pooled from five randomised controlled trials (RCTs) of 1287 patients, the Highly Effective Reperfusion evaluated in Multiple Endovascular Stroke Trials (HERMES) collaboration, showed no heterogeneity across subgroups of patients with different characteristics in the benefit of EVT over standard medical treatment, with up to 7.3 hours of onset-to-puncture time.1 However, the odds of achieving a good 3-month outcome after EVT significantly declined with longer onset-to-treatment time intervals.2

    Four of the five RCTs in the HERMES collaboration had to some extent taken into account the infarct core, evidence of salvageable tissue or the collateral status in patient eligibility criteria.1 2 Data from earlier studies also demonstrated that patients with good pretreatment collaterals, and …

    View Full Text

    Footnotes

    • Contributors XL and DSL performed literature search and wrote the manuscript.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Patient consent Not required.

    • Provenance and peer review Commissioned; internally peer reviewed.

    Linked Articles

    • Cerebrovascular disease
      Collateral status affects the onset-to-reperfusion time window for good outcome
      Byung Moon Kim Jang-Hyun Baek Ji Hoe Heo Hyo Suk Nam Young Dae Kim Joonsang Yoo Dong Joon Kim Pyoung Jeon Seung Kug Baik Sang Hyun Suh Kyung Yol Lee Hyo Sung Kwak Hong Gee Roh Young-Jun Lee Sang Heum Kim Chang-Woo Ryu Yon-Kwon Ihn Byungjoon Kim Hong Jun Jeon Jin Woo Kim Jun Soo Byun Sangil Suh Jeong Jin Park Woong Jae Lee Jieun Roh Byoung-Soo Shin Oh Young Bang
      Journal of Neurology, Neurosurgery & Psychiatry 2018; 89 903-909 Published Online First: 08 Mar 2018. doi: 10.1136/jnnp-2017-317627